Literature DB >> 4700003

Safe prescribing in liver disease.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4700003      PMCID: PMC1589369     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  18 in total

1.  DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE.

Authors:  H UEDA; T SAKURAI; M OTA; A NAKAJIMA; K KAMII; H MAEZAWA
Journal:  Diabetes       Date:  1963 Sep-Oct       Impact factor: 9.461

2.  Morphine tolerance in hepatic cirrhosis.

Authors:  J LAIDLAW; A E READ; S SHERLOCK
Journal:  Gastroenterology       Date:  1961-03       Impact factor: 22.682

3.  Phenobarbital-induced changes in NADPH-cytochrome c reductase and smooth endoplasmic reticulum in human liver.

Authors:  M M Thaler; P R Dallman; J Goodman
Journal:  J Pediatr       Date:  1972-02       Impact factor: 4.406

4.  Prednisolone treatment of lupus nephritis: Effect of high doses on course of disease, renal function, histological lesions, and immunological reactions.

Authors:  I R Mackay; G Robson; D Chan
Journal:  Australas Ann Med       Date:  1970-05

5.  Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis.

Authors:  J D Maxwell; M Carrella; J D Parkes; R Williams; G P Mould; S H Curry
Journal:  Clin Sci       Date:  1972-08       Impact factor: 6.124

6.  Accentuation of carbon tetrachloride-induced cirrhosis by azathioprine in the rat.

Authors:  M D Reuber
Journal:  Arch Pathol       Date:  1970-12

7.  Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis.

Authors:  F Schaffner
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

8.  [Studies on the metabolism of azathioprine].

Authors:  J F Bach; M Dardenne
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1970-07-27

9.  Antidepressants and liver disease.

Authors:  M H Morgan; A E Read
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

10.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.